| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012817A1 Evolution and use of enzymes for combinathorial and medicinal chemistry |
| 02/22/2001 | WO2001012816A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 02/22/2001 | WO2001012815A1 Coxsackie virus-derived vector system for gene transfer |
| 02/22/2001 | WO2001012814A1 Ml-236b biosynthesis-associated dna |
| 02/22/2001 | WO2001012813A1 Gene encoding merozoite protein of babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012810A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 02/22/2001 | WO2001012809A2 Heterodimeric vegf variants used for inhibiting angiogenesis |
| 02/22/2001 | WO2001012808A1 Novel frizzled family genes 584 |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012804A2 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 02/22/2001 | WO2001012803A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 02/22/2001 | WO2001012802A1 Random mutagenesis and amplification of nucleic acid |
| 02/22/2001 | WO2001012801A2 Defense-related signaling genes and methods of use |
| 02/22/2001 | WO2001012800A2 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and dimorphecolic acid, a fatty acid containing a 9-hydroxy group and delta-10,12 conjugated double bonds |
| 02/22/2001 | WO2001012799A2 Regulatory sequences for pollen specific or pollen abundant gene expression in plants |
| 02/22/2001 | WO2001012798A2 Male sterile plants |
| 02/22/2001 | WO2001012797A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 02/22/2001 | WO2001012794A1 Alkaline xyloglucanase from malbranchea |
| 02/22/2001 | WO2001012793A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 02/22/2001 | WO2001012792A1 Phytase enzymes, nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
| 02/22/2001 | WO2001012791A1 Dna shuffling of dioxygenase genes for production of industrial chemicals |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012789A2 APOLIPOPROTEIN B mRNA-SPECIFIC RIBOZYME |
| 02/22/2001 | WO2001012788A2 Tryptase-like polypeptide ztryp1 |
| 02/22/2001 | WO2001012787A2 Chimeric dna/rna ribozymes containing propanediol |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012785A1 Ex vivo generation of functional osteoclasts from bone marrow in a three-dimensional bioreactor |
| 02/22/2001 | WO2001012782A2 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012674A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012666A1 Parvovirus ns1 variants |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012660A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 02/22/2001 | WO2001012659A2 Human dna sequences |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012235A2 Targeted artificial gene delivery |
| 02/22/2001 | WO2001012234A1 Gene transfer imaging and uses thereof |
| 02/22/2001 | WO2001012231A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 02/22/2001 | WO2001012219A1 Pneumococcal vaccines |
| 02/22/2001 | WO2001012216A1 Heat shock fusion-based vaccine system |
| 02/22/2001 | WO2001012215A2 Protective antigen of epstein barr virus |
| 02/22/2001 | WO2001012213A2 Ttp-related zinc finger domains and methods of use |
| 02/22/2001 | WO2001012201A1 Blood plasma replacement solution |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012154A2 Targeted lipid particles |
| 02/22/2001 | WO2001012133A2 Cosmetic compositions with self-warming component |
| 02/22/2001 | WO2001012126A2 Cardiomyocyte regeneration |
| 02/22/2001 | WO2001011952A1 Transgenic prothrombin and related thrombin precursors and transgenics, methods, compositions, uses and the like relating thereto |
| 02/22/2001 | WO2001011951A1 Mouse having human cytochrome p450 transferred therein |
| 02/22/2001 | WO2001011950A1 Transgenic animals that produce altered wool |
| 02/22/2001 | WO2001011946A1 Construction of barley with decreased gel protein content |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000072863A3 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 02/22/2001 | WO2000072742A3 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/22/2001 | WO2000072008A3 Identification of novel mechanisms of drug resistance |
| 02/22/2001 | WO2000071737A3 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/22/2001 | WO2000071155A3 New vaccine formulations - 2 |
| 02/22/2001 | WO2000063394A3 A polypeptide having amidolytic activity for a serpin |
| 02/22/2001 | WO2000063385A3 Nucleic acid immunization |
| 02/22/2001 | WO2000061765A3 Lipoxygenase proteins and polynucleotides encoding the same |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000061731A3 Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
| 02/22/2001 | WO2000058483A3 Protozoan expression system |
| 02/22/2001 | WO2000057904B1 Attenuated dengue-3 virus vaccine |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000055314A3 Inhibitors of endothelin-1 synthesis |
| 02/22/2001 | WO2000054882A8 Individually addressable micro-electromagnetic unit array chips |
| 02/22/2001 | WO2000050613A8 Transgenic plants and method for transforming carnations |
| 02/22/2001 | WO2000049138A3 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of stomatic cells |
| 02/22/2001 | WO2000043521A3 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000039297A3 Il-1 related polypeptides |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000023100A8 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 02/22/2001 | WO2000022131A3 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2001 | WO1999058680A3 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 02/22/2001 | WO1999056771A3 Methods of raising animals for meat production |
| 02/22/2001 | WO1999049883A3 Oxidized thymosin beta 4 |
| 02/22/2001 | WO1999047553A3 Bacterial yeal family members as targets for antimicrobial drug design |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |
| 02/22/2001 | DE19939095A1 Von Coxsackieviren abgeleitetes Vektorsystem für Gentransfer Of coxsackie-derived vector system for gene transfer |
| 02/22/2001 | DE19937837A1 New human gene OLFXX, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/22/2001 | DE19937719A1 New nucleic acid from phage phiCh1, used to create vectors for expressing proteins and polymers in halophilic Archaea |